Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Glargine Insulin U-100	42	1,263
Total, all-cause mortality	Glimepiride	43	1,254
Total, all-cause mortality	Liraglutide	27	1,262
Total, all-cause mortality	Sitagliptin	41	1,268
Total, all-cause mortality	Study Run-In (Metformin Only)	0	7,850
Total, other adverse events	Glargine Insulin U-100	0	1,263
Total, other adverse events	Glimepiride	0	1,254
Total, other adverse events	Liraglutide	0	1,262
Total, other adverse events	Sitagliptin	0	1,268
Total, other adverse events	Study Run-In (Metformin Only)	0	7,850
Total, serious adverse events	Glargine Insulin U-100	259	1,263
Total, serious adverse events	Glimepiride	315	1,254
Total, serious adverse events	Liraglutide	204	1,262
Total, serious adverse events	Sitagliptin	272	1,268
Total, serious adverse events	Study Run-In (Metformin Only)	1	7,850

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01794143/event-totals